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There are three main legal approaches to drug use, each of which have their benefits and drawbacks—decriminalization, legalization and criminalization (Woods, 2011). Portugal, Canada and the United States all fall on this spectrum, and demonstrate possible outcomes of implementation of all three approaches. Decriminalization policy focuses on civil or administrative sanctions, but not criminal punishment (Woods, 2011). Proponents of this approach argue that criminal penalties harm the wellbeing of drug users, and make it harder to assist them in overcoming drug dependence. In addition, proponents contend that treating drug use as a crime wastes valuable resources on drug related law enforcement. 
The legalization approach focuses on consequentialist and rights based arguments. The consequentialist perspective argues that the advantages of prohibition do not outweigh the negative consequences of prohibitions (Woods, 2011) . The rights-based perspective argue that individuals have the moral right to do drugs, which is rooted in personal autonomy to make private decisions to one’s body. On the far end of the spectrum, criminalization proponents are rooted in treating drug use as a crime. One argument is based on denunciation, which justifies criminal punishment as a mechanism to communicate society’s disproval of a behavior. There are also arguments about retribution, meaning that drug users should be punished because drug use is inherently wrong and immoral. 
Finally, criminalization is rooted by the argument of deterrence—drug use would sky rocket if it would be readily available (Woods, 2011). By exploring each country’s public policy approach to illicit drugs, specifically opioids, there offers an opportunity to further understand how these policies affect access to public health interventions like harm reduction measures, and how access to such measures affect the public health of the injecting drug user community.  By analyzing regulation of illicit drug and use and regulation of harm reduction strategies, common themes can be generated that can contribute to future policy recommendations to best treat the health of injecting drug user population. 
2.0 	Harm Reduction Strategies 
Harm reduction is a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. In addition, harm reduction is also a movement for social justice built on a belief in, and respect for, the rights of people who use drugs. The philosophy of harm reduction has roots in a public health approach. It does not endorse drug use, but accepts drug use as a reality and focuses on reducing the possible harmful consequences (Hawk, Vaca, & D’Onofrio, 2015). The Harm Reduction Coalition ("Harm Reduction Coalition ", 2018) considers the following principles central to harm reduction practice: 
	Accepts, for better and or worse, that licit and illicit drug use is a part of our world and chooses to work to minimize harmful effects rather than simply ignore or condemn them
	Understands drug use as a complex, multi-faceted phenomenon that encompasses a continuum of behaviors from severe abuse to total abstinence, and acknowledges that some ways of using drugs are clearly safer than others
	Established quality of individual and community life and well-being—not necessarily cessation of all drug use—as the criteria for successful interventions and policies 
	Calls for non-judgmental, non-coercive provision of services and resources to people who use drugs and the communities in which they live in order to assist them in reducing attendant harm
	Ensures that drug users and those with a history of drug use routinely have a real voice in the creation of programs and policies designed to serve them
	Affirms drug users themselves as the primary agent of reducing harms of their drug use, and seeks to empower users to share information and support each other in strategies which meet the actual conditions of use
	Recognizes that the realities of poverty, class, racism, social isolation, past trauma, sex-based discrimination and other social inequalities affect both people’s vulnerability to and capacity for effectively dealing with drug related harm 
	Does not attempt to minimize or ignore the real and tragic harm and danger associated with licit and illicit drug use

Socially, harm reduction focuses on allowing people who use drugs to remain integrated in society. The alienation and marginalization associated with drug use often compounds the reasons why people who use drugs engage in unsafe drug use. Harm reduction privileges the safety of the individual and community over criminalization (Clarke 2016). In regards to the surrounding community, harm reduction intends to benefit through reducing open drug use, discarded drug paraphernalia, drug related crime and associated health, enforcement and criminal justice costs. 
Economically, harm reduction intends to reduce health care costs by reducing drug-related overdose, disease transmissions, injury and illness, as well as hospital utilization (Harm Reduction: A British Columbia Community Guide). Additionally, many harm reduction organizations have incorporated naloxone distribution into their scope of services. The logic behind these take home programs is that when it comes to reversing an opioid overdose, time matters (Hawk et al., 2015). 
2.1	Needle exchanges 
Needle exchange programs (NEPs) distribute sterile syringes and collect used syringes. The program is operated on the belief that every injection should be performed with sterile equipment. They are community based public health programs that provide comprehensive harm reduction services which usually includes the following (Syringe Services Programs 2017): 
	Sterile needs, syringes, and other injection equipment
	Safe disposal containers for needles and syringes
	HIV and hepatitis testing and linkage to treatment
	Education about overdose prevention and safer injection practices
	Referral to substance use disorder treatment, including medication assisted treatment
	Referral to medical, mental health and social services
	Tools to prevent HIV, STDs and viral hepatitis including counseling, condoms and vaccinations 

In 1982, injection drug users were first identified as a risk group for acquired immunodeficiency syndrome (AIDS). In 1984, the first government sponsored needle exchange program was launched in Netherlands. Needle exchanges were created in conjunction with prevention of the transmission of blood borne diseases in mind.  The primary goal of this specific program was to reduce the rate of hepatitis B, which at the time was affecting individuals at a staggering rate. However, needle exchanges began to appear in areas that were especially hit by the growing HIV/AIDS epidemic (Vlahov, 2001).  In 1988, physicians from the Amsterdam Municipal Health Service provided the first evaluation of the city’s program—it noted declines in the frequency of injecting and needle sharing among program participants. 
The primary goal of providing injection drug users with new, sterile injection equipment is to focus on the reduction of spread of blood-borne viruses or injection related infections. These programs have been shown to reduce the incidence of HIV and hepatitis C among addicts due to needle sharing and prevention accidental needle piercings from inappropriately discarded syringes (Coleman, 2015). It is also noted that need exchange programs are most effective when grouped with other services intended to target injection drug users. For example, services such as HIV testing and counseling, prevention and treatment of sexually transmitted infections, as well as prevention and vaccination programs for Hepatitis B and C (Coleman, 2015).  
Over the past 20 years, hundreds of studies have demonstrated that injecting drug users who use needle exchange programs are less likely to become infected with Hepatitis C and HIV. In ecological studies, it has been found that locales with needle exchange programs have lower rates of HIV incidence among injecting drug users as compared to those without needle exchange programs (Reasons, 2009). Research suggests that to be effective, needle exchange programs must have sufficient capacity to meet the needs of the community in which they are implemented. In addition, easy access is vital in ensuring the program reaches the target population (Coleman, 2015). There is proven evidence that needle exchanges are effective. In 1993, both the director of the Office or National Drug Control Policy, Robert Martinez, and the Director of the Centers for Disease Control and Prevention, William Roper, agreed to complete and objective review of needle exchange programs. This report was released by University of California and The US General Accounting Office (Vlahov, 2001). The report concluded that needle exchange programs, when properly implemented, reduced HIV infection and did not increase drug use. Furthermore, per the World Health Organization, “there no convincing evidence of major unintended consequences of programs providing sterile injection equipment to injecting drug users, such as initiation of injecting among people who have not injected previously, or an increase in the duration or frequency of illicit drug user or drug injection” (Coleman 2015). 
In addition, needle exchange programs have been proved to be a cost-effective measure. Research has consistently demonstrated that not only do needle exchanges save lives, but they also save money. A sterile syringe costs roughly $0.97, and the cost of averting a new HIV infection by providing syringe access ranges from $3,000-$50,000. In addition, the lifetime costs of treating someone with HIV can reach up to $618,000 (Drug Policy Alliance). In regards to Hepatitis C, the lifetime cost of treatment is found to be between $100,000 to $300,000. Ultimately, the United States can save billions of dollars by increasing access to sterile syringes to prevent injection related HIV and viral hepatitis infections (The Drug War: Fueling the HIV/AIDS Pandemic, 2014)
However, there are prevailing attitudes that lead to vocal opposition to utilization of needle exchange programs. Despite scientific evidence that needle exchange is the most effective way to prevent the spread of infectious disease among injecting drug users and protect the community, social anxiety remains focused on the addict (Clarke 2016). Opposition to needle exchanges have been ideological in nature, stemming from the political position that NEP’s “undercut the credibility of society’s message that drug use is illegal and morally wrong.” Related, federal funding to these programs would contradict law enforcement’s effort in the “war on drugs,” (Weinmeyer 2016). There is concern that needle exchange programs condone or send mixed signals about illicit drug use (Vlahov, 2001). In addition, critics of programs often claim that needle exchange programs facilitate addiction and by association increase the spread of communicable diseases (Coleman, 2015). A unique approach to understanding the backlash can be analyzed from the idea that once a topic is introduced into policy, there is an innate polarization associated. In other words, when needle exchanges were first introduced into the political process during the AIDS epidemic, in the legislative arena one must be for or against it (Moss, 200).  
2.2	Supervised Injection Sites 
Another method of harm reduction services is supervised injection sites. These facilities offer a safe, hygienic environment for people to inject their previously obtained drugs under supervision (Zaric, 2008). A study of the only supervised injection facility demonstrated that there was an association of an incremental net savings of almost $14 million and 920 life years gained over 10 years. When considering the health effect of increased use of safe injection practices, the net savings increased to more than $20 million and the number of life-years gained increased to 1070. Ultimately, Vancouver’s supervised injection site is associated with improved health and cost savings, even with conservative estimates of efficacy (Zaric, 2008).  
3.0 	Regulation of Illicit Drugs 
3.1	United States 
The United States take the criminalization approach to illicit drug use. On the federal level, the Controlled Substances Act (CSA), (Sacco, 2014) allows federal jurisdiction over specific plants, drugs, and chemical substances. It established a classification or scheduling system for drugs. Schedule I drugs have a high potential for misuse, no accepted medical treatment in the United States, and a lack of safety even if they were to be supervised by a medical professional. Heroin, gamma-hydroxybutyric acid (GHB), lysergic acid diethylamide (LSD), Quaaludes, and marijuana are examples of Schedule I drugs. 
The Controlled Substances Act was passed in 1970 during the Nixon Administration, and was a piece of the “War on Drugs,” movement sweeping the country. Proponents of “War on Drugs,” policies claim that such policies reduce drug related crime, decrease drug related disease and overdose, and are an effective means of disrupting and dismantling organized criminal enterprises (Coyne & Hall, 2017). As criminalization of drug use emerged as the dominant policy towards drug use, abstinence was seen by social and health care as the primary way to approach addiction (Clark 2016). This approach was one of the facilitators of the stigma surrounding illicit drug use. In many communities, illicit drug users were (and still are) negatively portrayed and labeled as social deviants, and this stigmatization continues to contribute to negatively affecting drug user’s mental and physical health (Latkin et al., 2010)
President Reagan continued the movement, and stressed the importance of criminal justice agencies in the federal government’s progress in combating drug abuse (Sacco, 2014). This was demonstrated when federal drug convictions rose sharply between 1980 and 1986. The total number of individuals convicted of federal drug offenses more than doubled from 5,244 in 1980 to 12,285 in 1986 (Sacco, 2014). Another piece of legislation in the realm of “War on Drugs,” was the Comprehensive Crime Control Act of 1984; Title II of P.L. 98-473, that, among other things, enhanced penalties for Controlled Substance Act violations, as well as amended the CSA to establish general criminal penalty provisions for certain felony drug violations (Sacco, 2014). 
Since the War on Drugs began more than 40 years ago, the United States government has spent more than $1 trillion on interdiction policies. Spending continues to cost U.S. taxpayers more than $51 billion annually (Coyne & Hall, 2017). Unfortunately, there are little positive outcomes associated with the War on Drugs movement. During this time, overdose deaths and drug related illnesses continued to climb. In 1971, the CDC reported that slightly more than 1 death per 100,000 people in the United States was related to drug overdose (Coyne & Hall, 2017). Today, this number is close to 20 per 100,000 (CDC, 2017a) 
In regards to legislation involving funding of needle exchanges, The Consolidated Appropriations Act of 2016 includes language in Division H, Sec. 520 that gives states and local communities, under limited circumstances, the opportunity to use federal funds to support certain components of needle exchange programs. Federal funds can be used to support a comprehensive set of services, but they cannot be used to purchase sterile needles or syringes for illegal drug injection (Syringe Services Programs 2017). 
In addition, the United States policies related to needle exchanges focus only on federal funding, and lack clarity on implementation. The process to receive federal funds is based on determination of need and then the requirement to apply to federal agencies to request approval to redirect fund. The demonstration of need is based on two scenarios—jurisdictions experiencing increases and jurisdictions at risk for but not yet experiencing increases. The demonstration of need requires present data for surveillance of acute hepatitis C and HIV, in combination with providing evidence that the increase in infections resulted from injection drug use. After that is submitted to the CDC, the process to submit a request for determination of need begins. Once the CDC notifies if the evidence is sufficient, the health department may then apply to direction funds to the respective federal agency. If the evidence is insufficient, no programmatic or budgetary change will be authorized (Paz-Bailey 2016). 
On the state level, each state has individual laws regarding drug offenses, and these laws can be very different. States each have their own statutory authorities, scheduling bodies, and control substances acts, though federal agencies can take over jurisdiction at any time. Most drug offenses are handled at the state level.
The legality of needle exchanges is determined by each state and is focused on whether sterile syringes are defined as drug paraphernalia. Over time, some states have decriminalized distribution of syringes by removing the mention of syringes or explicitly excluding syringes from their drug paraphernalia laws, relaxing rules on sale via pharmacies, or by creating expectations to laws which allow syringes to be distributed in effort to prevent the spread of blood borne diseases. Specifically, jurisdictions that prohibit the sale or distribution of drug paraphernalia, 19 states and the District of Columbia have an exception that allows syringe distribution to individuals who participate in a syringe exchange program. Of the states that prohibit the sale of distribution of drug paraphernalia, 13 states and the District of Columbia do not define syringes as drug paraphernalia when an individual is participating in a syringe exchange program. Eight states have removed syringes from their definition of drug paraphernalia (Burris, 2017). 
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3.2	Canada 
In 1969, the Commission of Inquiry in the Non-Medical Use of Drugs was formed to address the growing concern about drug use and the appropriate action to take. Later known as the Le Dain Commission, they described and analyzed the social costs and individual consequences of criminalization policy, as well as took strides in developing harm reduction policies throughout Canada. However, after a few years, delayed action on the controversial issue led to a decline for demand for action, and attempts for decriminalization met with limited success (Harm Reduction in Canada). 
Canada’s most important piece of legislation dealing with illicit drugs are within the federal jurisdiction under The Narcotic Control Act and The Food and Drugs Act. In 1987, Canada’s Drug Strategy was inaugurated with new funding allocated in roughly equal amounts to a variety of enforcement, treatment and prevention activities (Pates & Riley, 2012). Although the predominant focus on illicit drugs is prohibition, the philosophy behind the strategy represented a tentative first step toward a harm reduction approach. This was focused on the emphasis on the demand (the user), versus the supply reduction (the seller). Although compared to the United States’ “War on Drugs,” it attempted to achieve a balance between the supply and demand sides. This was through greater emphasis on prevention and treatment measures. 
The Controlled Drugs and Substances Act established the statutory framework through which the federal government regulates the lawful production, possession, and distribution of controlled substances. This comprehensive drug law classified controlled substances under five schedules per (1) how dangerous they are, (2) their potential for abuse and addiction, and (3) whether they have legitimate medical use. It is Canada’s main drug control legislation. Canada’s drug laws are strictly federal—the provincial level is responsible for areas listen in Constitution Act, 1867, which include areas such as education, health care, some natural resources and road regulations. The municipal level is based in a city or town, and receive authority from provincial governments to control areas such as libraries, parks, community water systems and local police. 
Needle exchange programs can operate under amendments to the Criminal Code to make it illegal to knowingly import, export, manufacture, promote or sell illicit drug paraphernalia or literature. The provision or distribution of needles by the medical profession as a “medical device” as opposed to an “instrument for use,” and is not an offense under criminal code (Riley, 1998). In addition, the federal government provided funding and a comprehensive statement of need and directions that should be taken which encompassed AIDS prevention, treatment and research. The National AIDS Strategy committed to support research initiatives to address the issues of HIV Infection among people who use injection drugs. Through these initiatives, many of the early outreach programs for injection drug users were funded (Canadian Pharmacy paper). 
3.3	Portugal 
In 1947, a democratic revolution following a dictatorship ushered in influx of consumption of narcotic drugs. Although rates were not startling in comparison to other countries, the high prevalence of problematic consumption had citizens deeply concerned. Because of the post dictatorship economic status, the country did not have the resources to spend on a “war on drugs,” that several other countries were focusing on. Because of this, along with the expert opinion of multidisciplinary committee of experts assembled by the Portuguese government, a new approach was taken to solve the crisis. Beginning in the late 1980’s and 1990’s, problematic drug use, particularly intravenous heroin use, became more prevalent. There was a surge of open air drug markets and the use of drug in public. The among of individuals in Portugal arrested for drug offense between 1990 and 1999 tripled (3,586 to 13,020), and total drug offenses peaked in 2000. In addition, in 1999, Portugal had the highest rate of drug related AIDS cases in the European Union, and the second highest prevalence of HIV among injecting drug users (Laqueur, 2014).
On July 1, 2001, the Portuguese decriminalized the “consumption, acquisition, and the possession for personal use of narcotic drugs and psychotropic substances.” This does not translate to a legalization. The change in legislation is known as the 2001 Decriminalization Act. The Law 30/2000 states if a person caught using or possessing a small quantity of drugs for personal use (established by law, this should not exceed the quantity required or average individual consumption over a period of 10 days), where there is no suspicion of involvement in drug trafficking, will be evaluated by a local Commission for the Dissuasion of Drug Addiction, composed of a lawyer, a doctor and a social worker. Punitive sanctions can be applied, but the main objective is to explore the need for treatment and to promote healthy recovery. The guidelines set out advise the Commission members to consider the circumstances of the infraction—whether the use was in public or private space, type of drug, and the consumer’s frequency of use, in addition to the user’s economic and financial circumstances (Laqueur, 2014). If the amount surpasses what is deemed personal use, the individual is still severely punished in accordance to the law, which is defined by incarceration (Cabral, 2017). 
Syringe exchange schemes are clearly regulated by Arts 50-57 of Decree-Law 183/2001 of 21st of June 2001. This includes provisions on management, access rights, working hours and procedures, premises and location (including the possibility of dispensing machines), coordination with other bodies and assessment. Under this text, injecting drug users can carry sterile injecting material (Portugal Country Drug Report 2017, 2017). 
4.0 	Regulation of Harm Reduction Measures 
4.1	United States 
The United States has one of the lowest rates of needle availability in the developed world. Needle exchanges came to the United States when an activist, Jon Parker, began distributing needles to injection drug users in New England municipalities—he was also being repeatedly arrested for such action (Vlahov, 2001). Publicly supported needle exchange programs opened in the United States in Tacoma, Washington, and then expanded further into New York City, Portland as well as San Francisco. The proliferation of such programs was attributed to the rising HIV/AIDS epidemic. These programs started with severe restrictions, and seemed to continue to operate in a hush manner. In 1988, after North Carolina Jesse Helms equated needle exchange programs with a federal endorsement of drug abuse, Congress enacted a ban on the use of federal funds for such programs (Weinmeyer 2016). The ban, created through the Public health and Welfare Act, section 300ee-5 stated hypodermic needles were banned unless “the Surgeon General of the United States determines that a demonstration needle exchange program would be effective in “reducing drug abuse and the risk that the public will become infected with the etiologic agent for acquired immune deficiency syndrome” (Weinmeyer 2016). In addition, more stringent language was added into the Comprehensive Alcohol Abuse, Drug Abuse and Mental Health Amendment Act of 1988. This specified that no funding could be spent to “carry out a program of distributing needles for the hypodermic injection of any illegal drug or distributing bleach for cleansing needles for such hypodermic injection (Vahlov 2001). Most importantly, another memo was circulated to principal investigators funded by the National Institute on Drug Abuse stating that existing National Institutes of Health projects were not permitted to evaluate needle exchange programs—they were told their proposals submitted would not be reviewed (Vaholv 2001). Limited needle exchange research was conducted—support came from private foundations, most notably the American Foundation for AIDS Research and the Robert Wood Johnson Foundation. Because of the private funding, in the 1990’s, scientific evidence emerged demonstrating the effectiveness of SEP’s demonstrating that they do in fact demonstrate effectiveness in preventing blood borne infections (Wilson, Donald, Shattock, Wilson, & Fraser-Hurt, 2015). It is important to note too that most of the larger, better documented needle exchanges program evaluations have been located outside the United States because of the funding and administrative bans (Coleman 2015). Ultimately, the administrative ban on research to evaluate the safety and effectiveness of such programs continues to be one of the biggest barriers to program implementation. There is irony in legislation to ban funds because the reasoning was because it could not be determined that such programs were shown to be effective; yet there was an administrative ban on research to evaluate the programs (Vahlov).  
During the Clinton administration, Congress passed Public Law 105-78, which allowed Congress to fund needle exchange programs if the Secretary of Health and Human Services endorsed the scientific evidence backing the programs. In 1997, Secretary Shalala (Democrat), did just that, but due to pressure from members of Congress and his administration’s Director of National Drug Control Policy, the ban was maintained (Fisher). Even within President George W. Bush’s President’s Emergency Plan for AIDS Relief (PEPFAR), there was writing to abide the ban. In 2009, Congress lifted the prohibition on federal funding through the Consolidated Appropriation Act by removing language in President Obama’s proposal that endorsed federal restriction. Prior to the ban being lifted, 16 states had provisions that authorized needle exchange programs. In 2011, this was reversed, and the 112th Congress banned needle exchange programs again to compromise on a budget bill. Finally, in 2016, the budget agreement allowed for high risk communities to use federal funds for services associated with needle exchange programs (Obama White House). This was through the Consolidated Appropriations Act, which modifies the restriction on federal funds for HHS programs distributing sterile needles or syringes for hypodermic injection of any illicit drug. However, it is important to note that federal dollars can only contribute to certain pieces of the programs—basically every component that is not a physical sterile needle Paz-Bailey 2016). This includes staff, supplies like alcohol pads or cotton, navigation services, disposal services, condom, testing kits for viral hepatitis or HIV/AIDS, and education materials. Federal funds cannot be used for needles and syringes or other devices used for illegal drug injection (examples would be a cooker). 
At the end of 2015, an estimated 1.1 million people were living with HIV/AIDS in the United States (CDC). Reported cases of Hepatitis C increased more than 2.9 fold from 2010 to 2015. Several early investigations of newly acquired HCV infections reveal that most occur among young, white persons living in non-urban areas (CDC, 2017b). This rise has been associated with rising rates of injection-drug use. The United States history regarding the policy of needle exchanges demonstrates the gigantic administrative hurdle these programs have faced since the inception of the idea. Studies were blocked even when early research suggested that needle exchanges might be a promising approach to HIV prevention. Blocking of federal funds further crippled the implementation of programs. Politics also played a large role in barrier needle exchanges faced through the years. 
4.1.1	Public Health Impact (Indiana) 
To demonstrate the public health impact laws related to access of needle exchanges and blood borne disease transmission, Indiana provides the best demonstration of negative outcomes. The Scott Township, Indiana HIV outbreak began in November 2015, with 11 new HIV infections diagnosed by January. It is important to note that Scott County had been without an HIV testing center since early 3012, when the sole provider—a Planned Parenthood clinic—closed (Rich 2015). To understand the weight of the outbreak, from 2009 to 2013 the county only reported three new cases of HIV (Worcester 2015). On January 23, 2015, the Indiana State Department of Health began investigating these infections. All 11 HIV infected persons reporting having injected the extended release formulation of the prescription opioid oxymorphone (Rich 2015). In response to this, after many weeks receiving information and data, Governor Mike Pence declared a public health emergency through an executive order. The SEA 461 allowed counties to create needle exchange programs as a part of holistic public health response to locally declared hepatitis C or HIV epidemics (Silverman 2015). At this point, there were 181 confirmed cased of HIV in Scott Township, a population of 4,200 people (Rich 2015). Scott County was approved to create a needle exchange program. Unfortunately, the legislation was made with the compromise that there was a one-year limit on programs and there was a requirement that a public health emergency was declared (Gross 2016). Even after signing the legislation, Governor Mike Pence opposes needle exchanges as anti-drug policy, and it was for the sole purpose of addressing the epidemic in Scott County for the duration of the declared emergency (Gross 2016). Unfortunately, SEA 461 will not solve Indiana’s public health problem because it does not allow the creation of statewide programs or address the underlying social determinants of health contributing to the HIV epidemic (Silverman 2015). 
4.1.2	What did Indiana teach us?
This outbreak offers several important insights that may help future outbreaks in similar communities. First, the patients were detected during routine HIV screening and by an alert disease intervention specialist. One of the main roles of needle exchange programs is access to testing for both HIV and Hepatitis C (Drug Policy Alliance). Prior to the outbreak, the only place to receive free HIV testing was Planned Parenthood, which closed in this community in 2013. Related, this outbreak demonstrates the importance of timely HIV surveillance activity and rapid response to interrupt disease transmission (Worcester 2015). Third, a reactive public health intervention hindered the health department’s ability to prevent such an outbreak. Proactive public health interventions are needed to prevent or limit future HIV and HCV outbreaks. The current wording of Indiana’s law continues to have a reactive answer—syringe exchange programs can be implemented in response to an increase in rates (Peters et.al, 2016). Finally, this outbreak highlights the vulnerability of the growing numbers of persons who inject drugs, especially in rural communities. Specifically, vulnerability related to blood borne pathogens such as HIV and HCV. Once the needle exchanges were put into place in Scott Township, HIV rates immediately dropped by 54%, and continue to decline (Peters et.al, 2016). 
Substantial barriers to syringe exchange programs continue to affect the health of communities, and Scott Township proved that. Continued efforts to amend wording of state laws, ensuring federal funding remains for such programs, and understanding the stigma related to people who inject drugs will all work towards ensuring outbreaks like this do not take step to the national level. Public health will continue to play a major role in ensuring the lives of people who inject drugs are protected. Local health departments should ensure complete contract tracing for new diagnoses and testing of all contacts, ensuring that people who inject drugs and those at high risk of drug injection have access to integrated prevention services. In addition, local health departments should notify state health departments and the CDC of any suspected clusters of HIV or HCV (Worcester 2015). 
4.2	Canada 
In 1988, the Federal Minister of Health openly supported needle exchanges, and the first needle exchange program was opened in Vancouver. Montreal and Toronto quickly followed suit and opened facilities in their cities (Vhalov).  As many countries, the real impetus for needle exchanges was the rise of HIV infection among injection drug users. One of the most distinctive pieces of Canada’s needle exchange program history was in 1997 when a research group in Vancouver presented results at a scientific meeting of a sharp increase in HIV prevalence among injection drug users, despite the long-term existence of local needle exchange programs. The literature suggests that under-provisioning due to an unforeseen increase in demand for syringes contributed to the Vancouver program’s inability to effectively combat the HIV/AIDS epidemic (Coleman). This further suggests that in order to be effective, needle exchange programs must have sufficient capacity to meet the needs of the community in which they are implemented, as well as they must be easily accessible by their target populations. This continues to be a barrier in all countries, not just Canada. 
4.3	Portugal 
The governance and implementation of harm reduction services within Portugal occurs within the framework of the Operation Plan of Integrated Responses. This plan is managed by Serviço de Intervenção nos Comportamentos Aditivos e nas Dependências (SICAD), and is focused on regional divisions and authorities of health. Portugal’s harm reduction strategies include needle exchanges, low threshold substitution programs, drop in centers and shelters, contact unites and outreach teams. Specifically, the National Commission for the Fight Against AIDS implements the national needle and syringe program known as Say No to a Used Syringe. From October 1993 to December 2015, over 54 million syringes were distributed under this program (Portugal Country Drug Report 2017, 2017). Harm reduction has become an integrated part of the services provided by the national network of health service providers. Treatment for HIV, AIDS and HCV is included in the range of services provided by the National Health Service of Portugal and is available free of charge. 
5.0 	Policy Recommendations
The ideological nature of opposition to needle exchange programs is a large barrier in the sphere for policy change. As demonstrated in Indiana, Republican leadership eventually allowed needle exchanges (although heavily restricted) to operate once there was a full-blown HIV epidemic. However, the shifting dialogue of what defines a “drug addict,” may be the impetus needed to increase access to harm reduction measures like the needle exchanges.  Perceptions of the users form the basis of policy narratives of drug control and addiction treatment, rather than the structural causes that often shape addiction (Clark 2016). 
The first and most important recommendation is to increase to advocacy surrounding needle exchange programs. An analysis completed in 2015 reports that more liberal political ideology and stronger belief that people who inject drugs deserve help rather than punishment were all significantly related to more support of needle exchanges (Kulesza, Teachman, Werntz, Gasser, & Lindgren, 2015). Political ideology continues to play an important role in support toward harm reduction measures, and therefore will require far more advocacy due to the current administration’s values. The need to improve health outcomes for people who inject drugs, specifically reducing the high and increasing rates of HIV and HCV transmission, remains an urgent task for health providers and our government (Wilson et al., 2015). Currently, needle exchanges most often must advocate for itself amidst the prevailing state and local political winds and narratives that view drug users as flawed individuals (Clarke 2016). The work they are doing needs to receive support first from the local governments and surrounding communities and then build outwards. 
The next recommendation is having states legally make syringes more accessible. Due to state by state politics though, this will happen at different speeds. Currently, Alaska is the only state to not prohibit the sale and distribution of drug paraphernalia, which syringes are considered a part of (Burris, 2017). Many argue this would open a floodgate of other concerns, so the recommendation to the state would be to exclude syringes as drug paraphernalia. This can be further controlled by adding specific exceptions for participants in syringe exchange programs. It is important to create this through the entire state law rather than local ordinances. For example, in Pennsylvania, syringe exchange programs operate under local authorizations in Philadelphia and Allegheny County (Burris, 2017). This creates a burden on local authorities—what happens when an individual crosses county lines? By changing state laws, there will be limited confusion and burden on local authorities. 
Another example of a state law change could be still prohibiting the sale or distribution of drug paraphernalia, but exception to the law that would allow for the distribution of syringes to prevent blood borne disease transmission. This would allow for the operation of needle exchange programs, and would require each exchange to have a “membership” that would ensure if stopped on the street outside of the exchange, individuals would have representation of membership status. This membership status is already a common best practice of needle exchange programs. 
Related to the accessibility, if removal of syringes as drug paraphernalia is unattainable, another approach could be the decriminalization of syringes as drug paraphernalia and the allowing for the distribution of syringes at pharmacies. Because of the widespread impact of the opioid epidemic, I compare the future of syringe access to the expansion of naloxone access. As rates of opioid overdoses increased, legislation was created to ensure naloxone was more accessible to the general population. This was a form of harm reduction policy making. 
The third recommendation would be on a federal level, and would require the Secretary of Health and Human Services to act on the declaration of the Public Health Emergency under the Public Health Emergency Act. This could allow for modifications that would allow for additional resources and suspension of regulatory barriers such as information sharing between state lines (Association of State and Territorial Health Officials). More assistance to local governments could ensure an increase of federal funding for needle exchange programs, as well as waive certain dispensing requirements that could affect access to syringes. Yes, states are at the front line of the opioid epidemic, but the declaration of a Public Health Emergency could ensure the supports are in place to improve the health of people who inject drugs. Unfortunately, there has been no action to date on this declaration. Since the initial declaration, there have been a few congressional hearings reiterating the problem. However, not one new dollar has been appropriated by Congress since the emergency was declared (Fraser, 2018). In addition, the Public Health Emergency Fund, which could be tapped by HHS in this declaration, only has $57,000 total (Ehley 2018). This declaration is giving the public the idea that something is being done by the administration to combat the crisis, when in reality the effort remains stagnant. 
6.0 	Conclusion 
Needle exchanges have been endorsed or supported by the federal Substance Abuse and Mental Health Services Administration, the Centers for Disease Control, U.S Surgeon General, the World Health Organization, the American Medical Association, The National Institutes of Health, and the United Nations on Drugs and Crime. One of the main organizations to ally with is the North American Syringe Exchange network (NASEN), which serves to support NEPs, expand and support the network of the exchange, and to disseminate information related to needle exchanges. Another organization important in making change in this area is the Harm Reduction Coalition, which focuses efforts to advancing harm reduction policies, practices and programs that address the adverse effects of drug use including overdose, HIV, hepatitis C, addition and incarceration.  HIV/AIDS continuing education programs are vital in educating the public on how needles spread infectious diseases, as well as operative in educating on how needle exchanges fit into this framework.  
Based on the exploration of these three counties, there is a relationship between the level of criminalization of drugs and access to harm reduction measures. This relationship is fueled by the way drug use is perceived based on the laws that punish or regulate behavior surrounding different levels of substances. As the opioid epidemic continues to plague the country, blood borne disease transmission will continue to rise. The scientific evidence demonstrated the safety and efficacy of needle exchanges as lifesaving, harm reducing public intervention (Rich 2015). In addition, analysis of evidence in articles referenced in this paper concluded that needle exchange programs do not result in increased drug use among participants or the recruitment of first time drug users (Rich 2015).  












APPENDIX: COMPARATIVE POLICY CHART
Country	Regulation of Drugs	Regulation of Harm Reduction Measures 
United States	Federal: Controlled Substances Act (CSA), which allowed federal jurisdiction over specific plants, drugs, and chemical substances. It established a classification or scheduling system for drugs.Schedule I drugs have a high potential for misuse, no accepted medical treatment in the United States, and a lack of safety even if they were to be supervised by a medical professional. Heroin, GHB, LSD, Quaaludes, and marijuana are examples of Schedule I drugs.State: Each state has individual laws regarding drug offenses, and these laws can be very different. States each have their own statutory authorities, scheduling bodies, and controlled substance acts (​http:​/​​/​www.namsdl.org​/​library​/​7FD99F95-F6F2-5D27-5B6BBFA598F35DF4​/​" \t "_blank​) , though federal agencies can take over jurisdiction at any time. Most drug offenses are handled at the state level. 	The Consolidated Appropriations Act of 2016 includes language in Division H, Sec. 520 that gives states and local communities, under limited circumstances, the opportunity to use federal funds to support certain components of needle exchange programs.Federal funds can be used to support a comprehensive set of services, but they cannot be used to purchase sterile needles or syringes for illegal drug injection (CDC). 
Canada	The Controlled Drugs and Substances Act established the statutory framework through which the federal government regulates the lawful production, possession, and distribution of controlled substances. This comprehensive drug law classified controlled substances under five schedules per (1) how dangerous they are, (2) their potential for abuse and addiction, and (3) whether they have legitimate medical use. It became, and remains today, the legal framework through which the Drug Enforcement Administration (DEA) derives its authority. 	Canadian Criminal Code and the Food and Drugs Act exempt the distribution of NEPs from laws governing the possession and distribution of drug paraphernalia—as long as the needle is “represented for use in preventing” HIV infection (Weekes). In an exemption under Section 56 of the Controlled Drugs and Substances Act, Vancouver Coastal Health established a supervised injection facility (Weekes) 
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